Brainstorm Cell Therapeutics/ALS clinical trials

barbara

Pioneer Founding member
This company is starting ALS trials. The video explains what the company is working on.

US Clinical Trials
BrainStorm is working with the Northeast ALS (NEALS) consortium to design a Phase II clinical trial in the United States.

Pending FDA approval, we are hoping to begin the trial in early 2013 at Massachusetts General Hospital (MGH) and the University of Massachusetts Medical School.

The University of Massachusetts Medical School team will be led by Professor Robert H. Brown, MD, DPhil., Chair of the Neurological Department at University of Massachusetts Medical School. Professor Brown is a leading expert in neuromuscular genetics and is world renowned for his expertise in ALS.

The MGH team will be led by Prof. Merit Cudkowicz, an expert in clinical trial design and therapy development for neurodegenerative diseases. She co-chairs the Northeast ALS consortium and directs the MGH Neurological Clinical Research Institute (NCRI).


http://www.youtube.com/watch?v=yLLkFAVxqM4
 
Top